Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Long-term Investment Intensity

Latest as of September 2019: 11.3%

Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Long-term Investment Intensity of 11.3% as of September 2019. Long-term investments of CN¥852.93 Million represent 11.3% of total assets of CN¥7.55 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 600329 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

11.3%
LT Investments / Total Assets

Long-term Investments

CN¥852.93 Million
CNY

Total Assets

CN¥7.55 Billion
CNY

Country

China
SHG

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Long-term Investment Intensity (2015–2018)

This chart shows how Tianjin Zhongxin Pharmaceutical Group Corp Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 11.3%, reflecting long-term investments of CN¥852.93 Million against total assets of CN¥7.55 Billion CNY. For the complete balance sheet picture, see 600329 total assets.

Annual Long-term Investment Intensity for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2015–2018)

The table below presents the year-by-year Long-term Investment Intensity for Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 2015 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 600329 liabilities breakdown for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 10.9% CN¥773.01 Million CN¥7.11 Billion ▼ -7.6 pp
2016 18.5% CN¥1.18 Billion CN¥6.36 Billion ▲ +4.7 pp
2015 13.8% CN¥835.72 Million CN¥6.07 Billion
pp = percentage points